BACKGROUND: Timely diagnosis of dementia is a global healthcare priority, particularly in low to middle income countries where rapid increases in older adult populations are expected. OBJECTIVE: To investigate global perspectives on the role of brief cognitive assessments (BCAs) in dementia diagnosis, strengths and limitations of existing measures, and future directions and needs. METHODS: This is a qualitative study of 18 dementia experts from different areas of the world. Participants were selected using purposeful sampling based on the following criteria: 1) practicing in countries with projected growth of older adult population of over 100%by 2050; 2) expertise in dementia diagnosis and treatment; 3) involvement in clinical practice and training; and 4) recognition as a national dementia expert based on leadership positions within healthcare system, research, and/or policy work. Participants were individually interviewed in their language of choice over secure videoconference sessions. Interviews were analyzed by a multidisciplinary team using theme identification approach. RESULTS: Four domains with subthemes emerged illustrating participants' perspectives: 1) strengths of BCAs; 2) limitations of BCAs; 3) needs related to the use of BCAs; and 4) characteristics of an ideal BCA. While most experts agreed that BCAs were important and useful for dementia diagnosis, the themes emphasized the need for development and validation of novel measures that are sensitive, psychometrically sound, and culturally appropriate. CONCLUSION: BCAs are important for guiding diagnosis and care for dementia patients. Findings provide a roadmap for novel BCA development to assist in diagnostic decision making for clinicians serving a rapidly growing and diverse dementia population.
BACKGROUND: Timely diagnosis of dementia is a global healthcare priority, particularly in low to middle income countries where rapid increases in older adult populations are expected. OBJECTIVE: To investigate global perspectives on the role of brief cognitive assessments (BCAs) in dementia diagnosis, strengths and limitations of existing measures, and future directions and needs. METHODS: This is a qualitative study of 18 dementia experts from different areas of the world. Participants were selected using purposeful sampling based on the following criteria: 1) practicing in countries with projected growth of older adult population of over 100%by 2050; 2) expertise in dementia diagnosis and treatment; 3) involvement in clinical practice and training; and 4) recognition as a national dementia expert based on leadership positions within healthcare system, research, and/or policy work. Participants were individually interviewed in their language of choice over secure videoconference sessions. Interviews were analyzed by a multidisciplinary team using theme identification approach. RESULTS: Four domains with subthemes emerged illustrating participants' perspectives: 1) strengths of BCAs; 2) limitations of BCAs; 3) needs related to the use of BCAs; and 4) characteristics of an ideal BCA. While most experts agreed that BCAs were important and useful for dementia diagnosis, the themes emphasized the need for development and validation of novel measures that are sensitive, psychometrically sound, and culturally appropriate. CONCLUSION: BCAs are important for guiding diagnosis and care for dementia patients. Findings provide a roadmap for novel BCA development to assist in diagnostic decision making for clinicians serving a rapidly growing and diverse dementia population.
Entities:
Keywords:
Alzheimer’s disease; cultural diversity; dementia; mental status and dementia tests; mild cognitive impairment
Authors: Sanne Franzen; Esther van den Berg; Miriam Goudsmit; Caroline K Jurgens; Lotte van de Wiel; Yuled Kalkisim; Özgül Uysal-Bozkir; Yavuz Ayhan; T Rune Nielsen; Janne M Papma Journal: J Int Neuropsychol Soc Date: 2019-09-12 Impact factor: 2.892
Authors: José Wagner Leonel Tavares-Júnior; Ana Célia Caetano de Souza; Gilberto Sousa Alves; Janine de Carvalho Bonfadini; José Ibiapina Siqueira-Neto; Pedro Braga-Neto Journal: Front Psychiatry Date: 2019-12-13 Impact factor: 4.157
Authors: Alissa Bernstein Sideman; Tala Al-Rousan; Elena Tsoy; Stefanie D Piña Escudero; Maritza Pintado-Caipa; Suchanan Kanjanapong; Lingani Mbakile-Mahlanza; Maira Okada de Oliveira; Myriam De la Cruz-Puebla; Stelios Zygouris; Aya Ashour Mohamed; Hany Ibrahim; Collette A Goode; Bruce L Miller; Victor Valcour; Katherine L Possin Journal: Front Neurol Date: 2022-03-28 Impact factor: 4.003